Oppenheimer & Co. Inc. Purchases 237 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Oppenheimer & Co. Inc. raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 35,663 shares of the financial services provider’s stock after acquiring an additional 237 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $5,193,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Avantax Advisory Services Inc. lifted its holdings in shares of iShares Biotechnology ETF by 38.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,287 shares of the financial services provider’s stock valued at $726,000 after purchasing an additional 1,466 shares during the last quarter. HBK Sorce Advisory LLC raised its stake in iShares Biotechnology ETF by 21.5% in the first quarter. HBK Sorce Advisory LLC now owns 2,812 shares of the financial services provider’s stock valued at $386,000 after buying an additional 498 shares during the last quarter. Blair William & Co. IL boosted its holdings in iShares Biotechnology ETF by 12.4% in the first quarter. Blair William & Co. IL now owns 50,747 shares of the financial services provider’s stock worth $6,963,000 after acquiring an additional 5,608 shares in the last quarter. Osaic Holdings Inc. grew its stake in shares of iShares Biotechnology ETF by 9.4% during the first quarter. Osaic Holdings Inc. now owns 160,173 shares of the financial services provider’s stock worth $21,985,000 after acquiring an additional 13,777 shares during the last quarter. Finally, Edgestream Partners L.P. purchased a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $436,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $140.09 on Friday. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57. The company’s 50 day moving average is $144.68 and its two-hundred day moving average is $141.56.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.